New Key Statistics Module, Z-Score and F-Score
OTCPK:SYMQY Key Ratios
| Market Cap $ M | 55.44 |
| Enterprise Value $ M | 11.40 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 2.04 |
| Price/Sales | 3.27 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 24.00 |
| EPS (TTM) $ | -0.55 |
| Beneish M-Score | -4.42 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -522.40 |
| EV-to-EBIT | -2.74 |
| EV-to-EBITDA | -2.74 |
| PEG | -- |
| Shares Outstanding M | 45.82 |
| Net Margin (%) | -92.66 |
| Operating Margin % | -67.15 |
| Pre-tax Margin (%) | -78.08 |
| Quick Ratio | 9.01 |
| Current Ratio | 9.12 |
| ROA % (ttm) | -41.98 |
| ROE % (ttm) | -46.64 |
| ROIC % (ttm) | -266.82 |
| Dividend Yield % | -- |
| Altman Z-Score | 4.34 |
SYMQY Number of Guru Trades
SYMQY Volume of Guru Trades
Gurus Latest Trades with OTCPK:SYMQY
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:SYMQY is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SymBio Pharmaceuticals Ltd Insider Transactions
No Available Data
News about OTCPK:SYMQY
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers